Saccharomyces cerevisiae is a model organism in eukaryote cell research and the workhorse for the biotechnology industry. In nature and the industrial setup, environmental perturbations act as stressing factors which challenge regulation of metabolic flux and can also lead to reduced performance in industrial applications.
Kinetic metabolic models are mathematical representations of a biological system that consider kinetic expressions such as rate constants. They describe the network structure, kinetic rate expressions and contain values for the parameters in these expressions [6]. Thus, these descriptions are well-suited to model time-dependent dynamics. A detailed explanation of the main components in a kinetic metabolic model can be seen in Box 1. Despite the progress attained with them, a consensus version with a full coverage of CCM has not yet been achieved.
| Rizzi et al. [19] | Teusink et al. [82] | Teusink et al. [22] | van Eunen et al. [17] | |
|---|---|---|---|---|
| Contribution to glycolytic understanding | Dynamic models can accurately describe glucose perturbation. | ATP surplus can cause the observed overactivation of initial glycolytic steps in DTps1 mutant strains. | In vivo behavior cannot be predicted with in vitro kinetics. | Implementation of allosteric regulation and in vivo measured parameter values is necessary to reproduce GP data. |
| GLYCO | Individual + branch reactions (++) | Lumped reactions (+) | Individual + branch reactions (++) | Individual + branch reactions (++) |
| TRE | N/A | N/A | N/A | T6P regulation (+) |
| TCA | Individual reactions (++) | N/A | N/A | N/A |
| PPP | N/A | N/A | N/A | N/A |
| Cofactors | Conservation moiety (+) | Conservation moiety (+) | Conservation moiety (+) | Conservation moiety (+) |
| Parameters | Computational, in vivo (++) | Computational, toy model (+) | Computational, in vivo (++) | Experimental and computational, in vivo (++) |
| Data | Single GP experiment (++) | Single GP, toy data (+) | SS data point (+) | Single GP experiment and multiple SS (+++) |
| Smallbone et al. [16] | Van Heerden et al. [18] | Messiha et al. [33] | Kesten et al. [20] | |
| Contribution to glycolytic understanding | Broad quantification of enzymatic kinetic constants in in vivo-like conditions. | Glycolytic dynamics combined with cell heterogeneity determine cell fate. | Feasibility of constructing larges network models by merging smaller pathway models. | Cooperativity PYK-PYR and ADH-PDH bypass play a major role in the onset of the Crabtree effect. |
| GLYCO | Individual + branch reactions + isozymes (+++) | Individual + branch reactions (++) | Individual + branch reactions (++) | Individual + branch reactions (++) |
| TRE | N/A | T6P regulation (+) | N/A | N/A |
| TCA | N/A | N/A | N/A | Individual reactions (++) |
| PPP | N/A | N/A | Individual reactions (++) | N/A |
| Cofactors | Conservation moiety (+) | Conservation moiety + dynamic Pi (++) | Conservation moiety (+) | Conservation moiety (+) |
| Parameters | Experimental, in vivo (++) | Experimental, in vivo (++) | Experimental, in vivo (++) | Computational, in vivo (++) |
| Data | N/A | Single GP experiment (++) | Single GP experiment (++) | Single GP experiment (++) |
| Rizzi et al. [25] | Theobald et al. [26] | Vaseghi et al. [21] | Visser et al. [27] | |
|---|---|---|---|---|
| Glucose input regime | Glucose-limited to glucose pulse (0.25 g L−1) | Glucose-limited to glucose pulse (1 g L−1) | Glucose-limited to glucose pulse (1 g L−1) | Glucose-limited to glucose pulse (1 g L−1) |
| Experimental setup | 30 °C, pH5, aerobic, D = 0.1 h−1, STR, direct sampling | 30 °C, pH5, aerobic, D = 0.1 h−1, STR, direct sampling | 30 °C, pH5, aerobic, D = 0.1 h−1, STR, direct sampling | 30 °C, pH5, aerobic, D = 0.05 h−1, STR, BioScope sampling |
| Duration | 500 s | 180 s | 180 s | 80 s |
| Strain | CBS 7336 (ATCC 32167) | CBS 7336 (ATCC 32167) | CBS 7336 (ATCC 32167) | CEN.PK113-7D |
| Measurement technique | Enzymatic assay | Enzymatic assay: metabolites, NAD(H) HPLC: adenine nucleotides | Enzymatic assay: metabolites, NAD(H) | Enzymatic assay: ATP, NADX and G6P MS: glycolytic intermediates |
| Intracellular variables measured | GLYCO: G6P. | GLYCO: G6P, F6P, FBP, GAP, 3PG, PEP, PYR. NUC: NAD(H), AXP (whole cell and cytoplasmic). Pi. | GLYCO: G6P, F6P. PPP: 6PG. NUC: NADP(H). | GLYCO: G6P, F6P, G1P, FBP, 2GP+3PG, PEP, PYR. NUC: ATP, NADX. |
| Glucose input regime | Glucose-limited to glucose pulse (1 g L−1) | Glucose-limited to glucose pulse (1 g L−1) | Glucose-limited to glucose pulse (1 g L−1) | Trehalose-limited to glucose pulse (20 g L−1) |
| Experimental setup | 30 °C, pH5, aerobic, D = 0.05 h−1, STR, BioScope sampling | 30 °C, pH5, aerobic, D = 0.05 h−1, STR, BioScope sampling | 30 °C, pH5, aerobic, D = 0.05 h−1, STR, direct sampling | 30 °C, pH4.8, aerobic, SF, direct sampling. |
| Duration | 180 s | 180 s | 300 s | 30 min |
| Strain | CEN.PK113-7D | CEN.PK113-7D | CEN.PK113-7D | BY4741 |
| Measurement technique | MS | Enzymatic analysis: NAD(H) MS | MS | MS |
| Intracellular variables measured | GLYCO: G6P, F6P, FBP, 2/3PG, PEP, PYR. TCA: ISOCIT, FUM, MAL, AKG, SUC. PPP: 6PG. TRE: G1P, T6P, TRE. NUC: AXP, NADH:NAD ratio. | GLYCO: G6P, F6P, F1,6P2, F2,6P2, 2/3PG, PEP. TCA: ISOCIT, AKG, SUC, FUM, MAL. PPP: 6PG. TRE: G1P, T6P. NUC: AXP, NADH:NAD ratio. | GLYCO: G6P, F6P, F1,6P2, F2,6P2, 2/3PG, PEP. TCA: ISOCIT, AKG, SUC, FUM, MAL. PPP: 6PG. TRE: G1P, T6P. NUC: AXP, NADH:NAD ratio. AAs. | GLYCO: G6P, F6P, FBP, G3P, 2/3PG, PEP. TCA: AKG, MAL. PPP: 6PG, R5P, R1P. TRE: T6P, G1P. NUC: ATP, ADP, AMP, IMP, INO, HYP, GTP, GDP, GMP. |
| Van Heerden et al. [18] | Suarez-Mendez et al. [36], Suarez-Mendez et al. [37] | Canelas et al. [34] | Kumar et al. [35] | |
| Glucose input regime | Glucose-limited to glucose pulse (20 g L−1) | Glucose-limited to feast–famine cycles (0.08 g L−1 max.) | Glucose-limited. Dilution rates from 0.025 to 0.375 h−1 | Glucose-limited. Dilution rates from 0.050 to 0.342 h−1 |
| Experimental setup | 30 °C, pH5, aerobic, D = 0.1 h−1, STR, BioScope sampling | 30 °C, pH5, aerobic, D = 0.1 h−1, STR, direct sampling | 30 °C, pH5, aerobic, STR, direct sampling | 30 °C, pH5, aerobic, STR, direct sampling |
| Duration | 340 s | 400 s | N/A (ss) | N/A (ss) |
| Strain | CEN.PK113-7D | CEN.PK113-7D | CEN.PK113-7D,mtlD1 | CEN.PK113-7D |
| Measurement technique | MS Reaction rates calculated by piecewise affine approximation (13C data) | MS Reaction rates calculated by piecewise affine approximation (13C data) | MS Reaction rates calculated with a stoichiometric model | MS |
| Intracellular variables measured | GLYCO: G6P, F6P, FBP. TRE: G1P, UDPG, T6P, TRE. PPP: 6PG. NUC: AXP, cAMP, UXP, GXP. Fluxes within glycolysis and trehalose cycle. | GLYCO: G6P, F6P, FBP, G3P, GLYC, DHAP, GAP, 2PG, 3PG, PEP, PYR. TCA: CIT, FUM, ISOCIT, MAL, AKG, SUC. PPP: 6PG, E4P, R5P, RBUP5, S7P, X5P. TRE: G1P, UDPG, T6P, TRE. NUC: AXP. Fluxes within glycolysis and trehalose cycle. | GLYCO: G6P, F6P, FBP, F26BP, G3P, DHAP, GAP, 2PG, 3PG, PEP, PYR. TCA: CIT, FUM, ISOCIT, MAL, OAA, SUC. PPP: 6PG, E4P, R5P, RBUP5, S7P, X5P. TRE: G1P, T6P, TRE. NUC: AXP, UXP, cAMP, NAD:NADH ratio. AAs. Fluxes within glycolysis. | GLYCO: G6P, F6P, FBP, G3P, DHAP, 2/3PG, PEP, PYR. TCA: CIT, FUM, OAA, ISOCIT, MAL, AKG, SUC. PPP: 6PG, R5P, RBUP5, S7P. TRE: G1P, UDPG. NUC: AXP, GXP, IXP, TXP, UXP, dAXP, dGXP, dUXP. AAs. |
This entry is adapted from the peer-reviewed paper 10.3390/metabo12010074